NEW DRUG APPROVED FOR ADVANCED RENAL CELL CANCER

被引：1
|
作者：
Aschenbrenner, Diane S. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA
来源：
AMERICAN JOURNAL OF NURSING | 2012年 / 112卷 / 05期
关键词：
D O I：
10.1097/01.NAJ.0000414312.49083.9b
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [31] New schizophrenia drug approved
    不详
    NURSE PRACTITIONER, 2009, 34 (11): : 56 - 56
  • [32] Sutent - Sunitinib - PFIZER - Kinase inhibitor approved for GIST and advanced renal cell carcinoma
    不详
    FORMULARY, 2006, 41 (02) : 56 - 56
  • [33] Eribulin approved for advanced breast cancer
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (01) : 6 - 6
  • [34] Olaparib Approved for Advanced Ovarian Cancer
    不详
    CANCER DISCOVERY, 2015, 5 (03) : 218 - 218
  • [35] Torisel approved for advanced kidney cancer
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (14) : 1460 - 1460
  • [36] Pazopanib for the treatment of advanced renal cell cancer
    Escudier, Bernard
    Albiges, Laurence
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (06): : 605 - 616
  • [37] Prognostic factors in advanced renal cell cancer
    Porta, Camillo
    Imarisio, Ilaria
    Paglino, Chiara
    Ferraris, Elisa
    Mensi, Mario
    Rovereto, Bruno
    EJC SUPPLEMENTS, 2008, 6 (14): : 35 - 37
  • [38] Targeted Therapies in Advanced Renal Cell Cancer
    Karaaslan, Sinan
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2015, 14 (03): : 210 - 213
  • [39] Immunotherapies in Early and Advanced Renal Cell Cancer
    Kasenda, Benjamin
    Larkin, James
    Gore, Martin
    IMMUNO-ONCOLOGY, 2015, 42 : 1 - 10
  • [40] New immunotherapy in the treatment of advanced renal cancer
    Muto, Andrea
    Gridelli, Cesare
    EXPERT OPINION ON EMERGING DRUGS, 2019, 24 (04) : 233 - 237
12345